Trial Profile
The Feasibility and Reliability of Utilizing Commercially Available Quantitative Analysis Software as an Adjunct to the Clinical Qualitative Interpretation of Amyvid Brain Scans
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2015
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Avid Radiopharmaceuticals
- 18 May 2015 New trial record